Acid suppression

Solutions of many antimony and bismuth salts hydrolyse when diluted the cationic species then present will usually form a precipitate with any anion present. Addition of the appropriate acid suppresses the hydrolysis, reverses the reaction and the precipitate dissolves. This reaction indicates the presence of a bismuth or an antimony salt. 

In this reaction, three steps, ie, acylation, cyclization, and replacement of the chlorine atom by the hydroxyl group, take place simultaneously in concentrated sulfuric acid. In the course of cyclization 2,7-dichlorofluoran (31) may be formed as a by-product presumably through the carbonium ion (30) ihustrated as follows. The addition of boric acid suppresses this pathway and promotes the regular cyclization to form the anthraquinone stmcture. The stable boric acid ester formed also enables the complete replacement of chlorine atoms by the hydroxyl group. Hydrolysis of the boric acid ester of quinizarin is carried out by heating in dilute sulfuric acid. The purity of quinizarin thus obtained is around 90%. Highly pure product can be obtained by sublimation. 

Acid-suppressing therapy is the mainstay of GERD treatment and should be considered for anyone not responding to lifestyle changes and patient-directed therapy after 2 weeks. 

Hour ambulatory pH monitoring may be the only way to objectively prove that symptoms are reflux-related in patients with atypical symptoms or non-erosive reflux disease. Ambulatory pH monitoring may also be useful in patients whose symptoms are not improving on adequate doses of acid-suppressing therapy. 

B. Standard dose acid-suppressing therapy Mild GERD can usually be treated effectively with... 

Rabeprazole 20 mg Palienls not responding to acid-suppressing therapy,... 

Antacids are an appropriate component of treating mild GERD, as they are clearly effective for immediate, symptomatic relief. They are often used concurrently with other acidsuppressing therapies. Patients who require frequent use of antacids for chronic symptoms should be treated with prescription acid-suppressing therapy. 

The combination of a prokinetic agent and acid-suppressing drug is used commonly in pediatric patients with GERD.27 Monotherapy with an H2RA is also used frequently ranitidine 2 to 4 mg/kg/day is effective in neonates and pediatric patients. 

Record the frequency and severity of symptoms by interviewing the patient after 6 to 8 weeks of acid-suppressing therapy. Continued symptoms may indicate the need for long-term maintenance therapy. 

Gastric outlet obstruction occurs in approximately 2% of patients with PUD and is usually caused by ulcer-related inflammation or scar formation near the peripyloric region. Signs and symptoms of outlet obstruction include early satiety after meals, nausea, vomiting, abdominal pain, and weight loss. Ulcer healing with conventional acid-suppressive therapy is the primary treatment, but if this is unsuccessful then an endoscopic procedure (e.g., balloon dilation) is required. 

HP infection because it has a sensitivity and specificity greater than 95% and a short turnaround time (2 days). Concomitant acid-suppressive or antibiotic therapy may give false-negatives with this test. 

The primary goal of HP therapy is to completely eradicate the organism using an effective antibiotic-containing regimen. Reliance on conventional acid-suppressive drug therapy alone... 

Determine the appropriate duration of therapy for acid-suppressive therapy. 

The incidence of community-associated C. difficile infection (defined as occurring in patients not hospitalized in the year prior to diagnosis) is increasing.36 In addition to antibiotic use, community-associated C. difficile cases are associated with the use of gastric acid suppressive agents (e.g., proton pump inhibitors and H2-receptor antagonists). 

Intravenous histamine-2-receptor antagonists such as ranitidine, famotidine, and cimetidine are compatible with PN and can be added to the daily PN for prevention of stress-related mucosal damage and peptic ulcer disease. This provides a continuous acid suppression and reduces nursing time by avoiding intermittent scheduled infusions. 

McCloy RF, Arnold R, Bardhan KD, Cattan D, Klinkenberg-Knol E, Maton PN, et al Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995 40 96S-120S. 

Evenepoel P, Claus D, Geypens B, Maes B, Hiele M, Rutgeerts P, et al Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther 1998 12 1011-1019. 

It should be mentioned that the inhibition of superoxide overproduction and lipid peroxidation by lipoic acid has been recently shown in animal models of diabetes mellitus. The administration of LA to streptozotocin-diabetic rats suppressed the formation of lipid peroxidation products [213], In another study the supplementation of glucose-fed rats with lipoic acid suppressed aorta superoxide overproduction as well as an increase in blood pressure and insulin resistance [214]. 

Antacids provide immediate, symptomatic relief for mild GERD and are often used concurrently with other acid-suppressing therapies. Patients... 

Antacids have a short duration, which necessitates frequent administration throughout the day to provide continuous acid neutralization. Typical doses are two tablets or 1 tablespoonful four times daily (after meals and at bedtime). Nighttime acid suppression cannot be maintained with bedtime doses of antacids. 

For typical symptoms, treat empirically with prescription-strength acid-suppression therapy. If symptoms recur, consider maintenance therapy (Ml). Note Most patients will require standard doses for MT. 

Promotility agents may be useful as adjuncts to acid suppression therapy in patients with a known motility defect (e.g., LES incompetence, decreased esophageal clearance, delayed gastric emptying). However, these agents are generally not as effective as acid suppression therapy and have undesirable side effects. 

Although treatment is minimally effective if used for 7 days, 10-14 days of treatment is recommended. The antisecretory drug may be continued beyond antimicrobial treatment in patients with a history of complicated ulcer (e g., bleeding or in heavy smokers). In the setting of an active ulcer, acid suppression is added to hasten pain relief. 

The risk of infection rises with conditions that increase gastric pH and subsequent bacterial overgrowth, such as obstruction, hemorrhage, malignancy, or acid-suppression therapy (clean-contaminated). 

---